# Commission Implementing Regulation (EU) 2016/1068 of 1 July 2016 approving N-cyclopropyl-1,3,5-triazine-2,4,6-triamine (cyromazine) as an existing active substance for use in biocidal products of product-type 18 (Text with EEA relevance), Introduction: Introductory text

Extent: E+W+S+N.I.

Commission Implementing Regulation (EU) 2016/1068
of 1 July 2016
approving N-cyclopropyl-1,3,5-triazine-2,4,6-triamine (cyromazine) as an existing active substance for use in biocidal products of product-type 18
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products, and in particular the third subparagraph of Article 89(1) thereof,
Whereas:
(1)
Commission Delegated Regulation (EU) No 1062/2014 establishes a list of existing active substances to be evaluated for their possible approval for use in biocidal products. That list includes N-cyclopropyl-1,3,5-triazine-2,4,6-triamine (cyromazine).
(2)
Cyromazine has been evaluated for use in products of product-type 18, Insecticides, acaricides and products to control other arthropods, as described in Annex V to Regulation (EU) No 528/2012.
(3)
Greece was designated as evaluating competent authority and submitted the assessment reports together with its recommendations on 28 August 2014.
(4)
In accordance with Article 7(2) of Delegated Regulation (EU) No 1062/2014, the opinion of the European Chemicals Agency was formulated on 10 December 2015 by the Biocidal Products Committee, having regard to the conclusions of the evaluating competent authority.
(5)
According to that opinion, biocidal products of product-type 18 and containing cyromazine may be expected to satisfy the criteria of Article 19(1)(b) of Regulation (EU) No 528/2012, provided that certain specifications and conditions concerning their use are complied with.
(6)
It is therefore appropriate to approve cyromazine for use in biocidal products of product-type 18, subject to compliance with certain specifications and conditions.
(7)
Since cyromazine meets the criteria for being very persistent (vP) according to Annex XIII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council, treated articles treated with or incorporating cyromazine should be labelled appropriately when placed on the market.
(8)
A reasonable period should be allowed to elapse before an active substance is approved in order to permit interested parties to take the preparatory measures necessary to meet the new requirements.
(9)
The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,
HAS ADOPTED THIS REGULATION:

---
Source: https://www.legislation.gov.uk/eur/2016/1068/introduction (the official version)
Page: https://openlegislation.uk/eu-regulation-2016-1068/introduction
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.